Dr. Jennifer McVige, director of the DENT Concussion Center, was honored as the Muscular Dystrophy Association’s 2018 Honoree. Dr. McVige received this prestigious award for her dedication to patients suffering from Neuromuscular disorders, especially her work with Spinraza, the breakthrough therapy for children suffering from Spinal Muscular Atrophy (SMA). According to the Muscular Dystrophy Association, SMA is a genetic disease affecting the part of the nervous system that controls voluntary muscle movement, taking away a person’s ability to walk, eat, and breathe. However, SMA does not affect a person’s ability to think and interact with others. SMA is the number one genetic cause of death in infants.
Dr. McVige was the first physician in New York to administer Spinraza to a pediatric patient.
“What is particularly special about her and what we cherish so much about her is her passion for her patients and her dedication to the community,” said CEO of DENT Neurologic Institute, Joseph Fritz.
Congratulations, Dr. McVige!